Publication:
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

dc.contributor.authorChen, Hongjie
dc.contributor.authorFan, Shaoqi
dc.contributor.authorStone, Jennifer
dc.contributor.authorThompson, Deborah J
dc.contributor.authorDouglas, Julie
dc.contributor.authorLi, Shuai
dc.contributor.authorScott, Christopher
dc.contributor.authorBolla, Manjeet K
dc.contributor.authorWang, Qin
dc.contributor.authorDennis, Joe
dc.contributor.authorMichailidou, Kyriaki
dc.contributor.authorLi, Christopher
dc.contributor.authorPeters, Ulrike
dc.contributor.authorHopper, John L
dc.contributor.authorSouthey, Melissa C
dc.contributor.authorNguyen-Dumont, Tu
dc.contributor.authorNguyen, Tuong L
dc.contributor.authorFasching, Peter A
dc.contributor.authorBehrens, Annika
dc.contributor.authorCadby, Gemma
dc.contributor.authorMurphy, Rachel A
dc.contributor.authorAronson, Kristan
dc.contributor.authorHowell, Anthony
dc.contributor.authorAstley, Susan
dc.contributor.authorCouch, Fergus
dc.contributor.authorOlson, Janet
dc.contributor.authorMilne, Roger L
dc.contributor.authorGiles, Graham G
dc.contributor.authorHaiman, Christopher A
dc.contributor.authorMaskarinec, Gertraud
dc.contributor.authorWinham, Stacey
dc.contributor.authorJohn, Esther M
dc.contributor.authorKurian, Allison
dc.contributor.authorEliassen, Heather
dc.contributor.authorAndrulis, Irene
dc.contributor.authorEvans, D Gareth
dc.contributor.authorNewman, William G
dc.contributor.authorHall, Per
dc.contributor.authorCzene, Kamila
dc.contributor.authorSwerdlow, Anthony
dc.contributor.authorJones, Michael
dc.contributor.authorPollan-Santamaria, Marina
dc.contributor.authorFernandez-Navarro, Pablo L
dc.contributor.authorMcConnell, Daniel S
dc.contributor.authorKristensen, Vessela N
dc.contributor.authorRothstein, Joseph H
dc.contributor.authorWang, Pei
dc.contributor.authorHabel, Laurel A
dc.contributor.authorSieh, Weiva
dc.contributor.authorDunning, Alison M
dc.contributor.authorPharoah, Paul D P
dc.contributor.authorEaston, Douglas F
dc.contributor.authorGierach, Gretchen L
dc.contributor.authorTamimi, Rulla M
dc.contributor.authorVachon, Celine M
dc.contributor.authorLindström, Sara
dc.contributor.funderUnión Europea. Comisión Europea. H2020es_ES
dc.contributor.funderCanadian Institutes of Health Researches_ES
dc.contributor.funderQuebec Breast Cancer Foundationes_ES
dc.contributor.funderGovernment of Quebec (Canadá)es_ES
dc.contributor.funderNational Institutes of Health (Estados Unidos)es_ES
dc.contributor.funderUnión Europea. Comisión Europea. 7 Programa Marcoes_ES
dc.contributor.funderCancer Research UK (Reino Unido)es_ES
dc.contributor.funderSusan G. Komen Breast Cancer Foundationes_ES
dc.contributor.funderOvarian Cancer Research Foundation (Astrualia)es_ES
dc.contributor.funderAustralian Breast Cancer Family Studyes_ES
dc.contributor.funderNIH - National Cancer Institute (NCI) (Estados Unidos)es_ES
dc.contributor.funderNational Health and Medical Research Council (Australia)es_ES
dc.contributor.funderNew South Wales Cancer Council (Reino Unido)es_ES
dc.contributor.funderVictorian Cancer Agencyes_ES
dc.contributor.funderNational Breast Cancer Foundation (Australia)es_ES
dc.contributor.funderCancer Australiaes_ES
dc.contributor.funderUniversitätsklinikum Erlangen (Alemania)es_ES
dc.contributor.funderConsorcio Gallego de Cáncer de Mama (BREOGAN)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)es_ES
dc.contributor.funderGalicia Sur Biomedical Foundationes_ES
dc.contributor.funderXunta de Galicia (España)es_ES
dc.contributor.funderMinisterio de Sanidad, Servicios Sociales e Igualdad (España)es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderCanadian Cancer Societyes_ES
dc.contributor.funderNIHR - Manchester Biomedical Research Centre (Reino Unido)es_ES
dc.contributor.funderCancer Council New South Wales (Australia)es_ES
dc.contributor.funderCancer Council Victoria (Australia)es_ES
dc.contributor.funderCancer Council Tasmania (Australia)es_ES
dc.contributor.funderCancer Council South (Australia)es_ES
dc.contributor.funderCancer Council Western Australia (Australia)es_ES
dc.contributor.funderUnited States Army Medical Research and Development Commandes_ES
dc.contributor.funderCancer Council Queensland (Australia)es_ES
dc.contributor.funderNIH - NCI-Specialized Programs of Research Excellence (SPORE) in Breast Cancer (Estados Unidos)es_ES
dc.contributor.funderVictorian Health Promotion Foundationes_ES
dc.contributor.funderThe Research Council of Norway (Noruega)es_ES
dc.contributor.funderSouthern and Eastern Norway Regional Health Authorityes_ES
dc.contributor.funderNorwegian Cancer Societyes_ES
dc.contributor.funderAgency for Science, Technology and Research (Singapur)es_ES
dc.contributor.funderInstitute of Cancer Research (Reino Unido)es_ES
dc.contributor.funderNIHR - Manchester Biomedical Research Centre (Reino Unido)es_ES
dc.date.accessioned2022-08-05T11:01:17Z
dc.date.available2022-08-05T11:01:17Z
dc.date.issued2022-04-12
dc.description.abstractBackground: Mammographic density (MD) phenotypes, including percent density (PMD), area of dense tissue (DA), and area of non-dense tissue (NDA), are associated with breast cancer risk. Twin studies suggest that MD phenotypes are highly heritable. However, only a small proportion of their variance is explained by identified genetic variants. Methods: We conducted a genome-wide association study, as well as a transcriptome-wide association study (TWAS), of age- and BMI-adjusted DA, NDA, and PMD in up to 27,900 European-ancestry women from the MODE/BCAC consortia. Results: We identified 28 genome-wide significant loci for MD phenotypes, including nine novel signals (5q11.2, 5q14.1, 5q31.1, 5q33.3, 5q35.1, 7p11.2, 8q24.13, 12p11.2, 16q12.2). Further, 45% of all known breast cancer SNPs were associated with at least one MD phenotype at p < 0.05. TWAS further identified two novel genes (SHOX2 and CRISPLD2) whose genetically predicted expression was significantly associated with MD phenotypes. Conclusions: Our findings provided novel insight into the genetic background of MD phenotypes, and further demonstrated their shared genetic basis with breast cancer.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by CA244670 and CA194393. European Union's Horizon 2020 Research and Innovation Programme (grant numbers 634935 and 633784 for BRIDGES and B-CAST respectively), and the PERSPECTIVE I&I project, funded by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, the Ministère de l’Économie et de l'Innovation du Québec through Genome Québec, the Quebec Breast Cancer Foundation. The EU Horizon 2020 Research and Innovation Programme funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report. Additional funding for BCAC is provided via the Confluence project which is funded with intramural funds from the National Cancer Institute Intramural Research Program, National Institutes of Health. Genotyping of the OncoArray was funded by the NIH Grant U19 CA148065, and Cancer UK Grant C1287/A16563 and the PERSPECTIVE project supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research (grant GPH-129344) and, the Ministère de l’Économie, Science et Innovation du Québec through Genome Québec and the PSRSIIRI-701 grant, and the Quebec Breast Cancer Foundation. Funding for iCOGS came from: the European Community's Seventh Framework Programme under grant agreement n° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, and Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund. The Australian Breast Cancer Family Study (ABCFS) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. J.L.H. is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow. M.C.S. is a NHMRC Senior Research Fellow. The Australian Mammographic Density Twins and Sisters Study (AMDTSS) was supported by the National Breast Cancer Foundation, Cancer Australia, the National Health and Medical Research Council of Australia, and facilitated by Twins Research Australia. The work of the BBCC was partly funded by ELAN-Fond of the University Hospital of Erlangen. The BCEES was funded by the National Health and Medical Research Council, Australia and the Cancer Council Western Australia and acknowledges funding from the National Breast Cancer Foundation (JS). The BREast Oncology GAlician Network (BREOGAN) is funded by Acción Estratégica de Salud del Instituto de Salud Carlos III FIS PI12/02125/Cofinanciado FEDER; Acción Estratégica de Salud del Instituto de Salud Carlos III FIS Intrasalud (PI13/01136); Programa Grupos Emergentes, Cancer Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur. Xerencia de Xestion Integrada de Vigo-SERGAS, Instituto de Salud Carlos III, Spain; Grant 10CSA012E, Consellería de Industria Programa Sectorial de Investigación Aplicada, PEME I + D e I + D Suma del Plan Gallego de Investigación, Desarrollo e Innovación Tecnológica de la Consellería de Industria de la Xunta de Galicia, Spain; Grant EC11-192. Fomento de la Investigación Clínica Independiente, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain; and Grant FEDER-Innterconecta. Ministerio de Economia y Competitividad, Xunta de Galicia, Spain. CBCS is funded by the Canadian Cancer Society (grant # 313404) and the Canadian Institutes of Health Research. FHRISK and PROCAS are funded from NIHR grant PGfAR 0707-10031. DGE, AH and WGN are supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007). kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia, The Cancer Foundation of Western Australia, Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; 400413, 400281, 199600). G.C.T. and P.W. are supported by the NHMRC. RB was a Cancer Institute NSW Clinical Research Fellow. LAMBDA The MCBCS was supported by the NIH grants R35CA253187, R01CA192393, R01CA116167, R01CA176785 a NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [P50CA116201], and the Breast Cancer Research Foundation. Melbourne Collaborative Cohort Study (MCCS) cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further augmented by Australian National Health and Medical Research Council grants 209057, 396414 and 1074383 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry and the Australian Institute of Health and Welfare, including the National Death Index and the Australian Cancer Database. The MEC was supported by NIH grants CA63464, CA54281, CA098758, CA132839 and CA164973. The MMHS study was supported by NIH grants CA97396, CA128931, CA116201, CA140286 and CA177150. The NBCS has received funding from the K.G. Jebsen Centre for Breast Cancer Research; the Research Council of Norway grant 193387/V50 (to A-L Børresen-Dale and V.N. Kristensen) and grant 193387/H10 (to A-L Børresen-Dale and V.N. Kristensen), South Eastern Norway Health Authority (grant 39346 to A-L Børresen-Dale) and the Norwegian Cancer Society (to A-L Børresen-Dale and V.N. Kristensen). The Northern California Breast Cancer Family Registry (NC-BCFR) and Ontario Familial Breast Cancer Registry (OFBCR) were supported by grant U01CA164920 from the USA National Cancer Institute of the National Institutes of Health. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The NHS was supported by NIH grants P01 CA87969, UM1 CA186107, and U19 CA148065. The NHS2 was supported by NIH grants UM1 CA176726 and U19 CA148065. The PBCS was funded by the Intramural Research Program of the National Cancer Institute, Department of Health and Human Services, USA. The SASBAC study was supported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. UKBGS is funded by Breast Cancer Now and the Institute of Cancer Research (ICR), London. ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. The replication of GWAS and TWAS results is supported by NIH grants R01CA166827, R01CA168893, and R01CA237541.es_ES
dc.format.number1es_ES
dc.format.page27es_ES
dc.format.volume24es_ES
dc.identifier.citationBreast Cancer Res. 2022 Apr 12;24(1):27.es_ES
dc.identifier.doi10.1186/s13058-022-01524-0es_ES
dc.identifier.e-issn1465-542Xes_ES
dc.identifier.journalBreast Cancer Research : BCRes_ES
dc.identifier.pubmedID35414113es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14868
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI12/02125es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI13/01136es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/634935/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/633784/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/223175/EUes_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s13058-022-01524-0es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBreast canceres_ES
dc.subjectGenome-wide association study (GWAS)es_ES
dc.subjectMammographic densityes_ES
dc.subjectTranscriptome-wide association study (TWAS)es_ES
dc.subject.meshBreast Densityes_ES
dc.subject.meshBreast Neoplasmses_ES
dc.subject.meshFemalees_ES
dc.subject.meshGenetic Predisposition to Diseasees_ES
dc.subject.meshGenome-Wide Association Studyes_ES
dc.subject.meshHumanses_ES
dc.subject.meshPhenotypees_ES
dc.subject.meshPolymorphism, Single Nucleotidees_ES
dc.subject.meshTranscriptomees_ES
dc.titleGenome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel locies_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationcb3b77d8-c78c-4238-9b9d-c1171ff3ab51
relation.isAuthorOfPublication204c29c1-c32f-483d-9ed7-1b12ec018754
relation.isAuthorOfPublication.latestForDiscoverycb3b77d8-c78c-4238-9b9d-c1171ff3ab51

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
GenomeWideAndTranscriptome_2022.pdf
Size:
1.63 MB
Format:
Adobe Portable Document Format
Description:
Artículo principal
Loading...
Thumbnail Image
Name:
GenomeWideAndTranscriptomeAdditionalFile1_2022.pdf
Size:
9.63 MB
Format:
Adobe Portable Document Format
Description:
Supplementary Information
Loading...
Thumbnail Image
Name:
GenomeWideAndTranscriptomeAdditionalFile2_2022.xlsx
Size:
3.42 MB
Format:
Microsoft Excel XML
Description:
Supplementary Information